Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 31, 2023

SELL
$92.52 - $104.91 $159,967 - $181,389
-1,729 Reduced 39.48%
2,650 $267,000
Q1 2023

Apr 21, 2023

SELL
$80.03 - $92.81 $8.4 Million - $9.74 Million
-104,921 Reduced 95.99%
4,379 $402,000
Q4 2022

Feb 01, 2023

BUY
$75.55 - $92.52 $29,237 - $35,805
387 Added 0.36%
109,300 $9.92 Million
Q3 2022

Oct 31, 2022

BUY
$74.61 - $87.26 $327,463 - $382,984
4,389 Added 4.2%
108,913 $8.28 Million
Q2 2022

Jul 22, 2022

BUY
$80.52 - $93.75 $357,428 - $416,156
4,439 Added 4.44%
104,524 $8.84 Million
Q1 2022

Apr 21, 2022

SELL
$80.11 - $90.62 $41,336 - $46,759
-516 Reduced 0.51%
100,085 $8.78 Million
Q4 2021

Jan 26, 2022

SELL
$79.7 - $88.13 $162,109 - $179,256
-2,034 Reduced 1.98%
100,601 $8.8 Million
Q3 2021

Oct 27, 2021

BUY
$81.78 - $95.14 $114,900 - $133,671
1,405 Added 1.39%
102,635 $8.39 Million
Q2 2021

Aug 02, 2021

BUY
$85.24 - $94.15 $269,273 - $297,419
3,159 Added 3.22%
101,230 $9.3 Million
Q1 2021

May 07, 2021

BUY
$83.5 - $98.47 $63,794 - $75,231
764 Added 0.79%
98,071 $8.38 Million
Q4 2020

Feb 02, 2021

BUY
$78.07 - $94.43 $121,633 - $147,121
1,558 Added 1.63%
97,307 $9.19 Million
Q3 2020

Nov 02, 2020

BUY
$82.14 - $91.0 $132,081 - $146,328
1,608 Added 1.71%
95,749 $8.33 Million
Q2 2020

Jul 29, 2020

BUY
$80.93 - $91.1 $308,667 - $347,455
3,814 Added 4.22%
94,141 $8.22 Million
Q1 2020

May 08, 2020

BUY
$70.67 - $99.01 $118,230 - $165,643
1,673 Added 1.89%
90,327 $7.45 Million
Q4 2019

Feb 06, 2020

BUY
$84.35 - $95.37 $7.48 Million - $8.45 Million
88,654 New
88,654 $8.39 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $212B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Trust CO Of Virginia Portfolio

Follow Trust CO Of Virginia and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trust CO Of Virginia , based on Form 13F filings with the SEC.

News

Stay updated on Trust CO Of Virginia with notifications on news.